PMA · Approved
Recalled · Class II · 2019Eversense Continuous Glucose Monitoring System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Senseonics, Incorporated · QCD Continuous Glucose Monitor, Implanted, Adjunctive Use
Approved on Jun 21, 2018 through premarket approval, which rests on the device’s own clinical evidence after a 603-day review. It has been recalled once.
- Decided
- Jun 21, 2018
- Review
- 603 days
- Class
- Class III
- Product code
- QCD
- Recalls
- 1
PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.
P160048 has 28 supplements since 2018: changes to the approved device, its labelling or its manufacturing, each approved separately.
PMA supplements approved per year
View FIG. 1 as a table
| Year | Supplements approved |
|---|---|
| 2018 | 4 |
| 2019 | 10 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QCD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
Does it have a predicate?
PMA decisions do not claim a predicate device.
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Sep 18, 2019 | Class II | Z-0251-2020 | Process control | Eversense Sensors have prematurely stopped functioning due to inadequate hydration of the sensor s glucose-sensing surface |
No ancestor or descendant has a Class I recall.
How does its category compare?
All QCD devicesQCD Continuous Glucose Monitor, Implanted, Adjunctive Use: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.
FDA decisions per year · QCD
2in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · QCD
Too few QCD 510(k)s in any year since 2007 to give a median.
Recalls per year · QCD
No recall names QCD since 2007.
Adverse event reports per year · QCD
364in 2024
MAUDE reports naming product code QCD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 5 | — | 0 | 3 |
| 2019 | 4 | — | 0 | 270 |
| 2020 | 0 | — | 0 | 576 |
| 2021 | 0 | — | 0 | 157 |
| 2022 | 0 | — | 0 | 29 |
| 2023 | 1 | — | 0 | 115 |
| 2024 | 2 | — | 0 | 364 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 1 | — | 0 | — |
https://510kreport.com/device/P160048 · printed Nov 6, 2026
Cite this page
510(k) Report. “P160048: Eversense Continuous Glucose Monitoring System.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P160048
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Page last updated Nov 3, 2026